Chris Duignan Joins Flourish Research as Chief Financial Officer
Retrieved on:
Tuesday, November 8, 2022
VP, United States Marine Corps Reserve, Industry, Duignan, NEW, Fairfield University, Naval and Marine Corps Reserve Center, Architecture, PricewaterhouseCoopers, New York Genome Center, CNS, DNA, Accounting, Vaccine, Clinical trial, Research, Diversified Pharmaceutical Services, Financial management, Management, Pharmaceutical industry, Science
NEW YORK, Nov. 8, 2022 /PRNewswire-PRWeb/ -- Chris Duignan has been named Chief Financial Officer of Flourish Research, a diversified clinical trial company designed to acquire, operate, and integrate large, best-in-class clinical research sites with expertise in studies spanning Phases I-IV.
Key Points:
- Chris Duignan, who has been named Chief Financial Officer of Flourish Research, will build the financial infrastructure, lead financial operations, and integrate the acquisitions of the rapidly growing organization.
- NEW YORK, Nov.8, 2022 /PRNewswire-PRWeb/ -- Chris Duignan has been named Chief Financial Officer of Flourish Research, a diversified clinical trial company designed to acquire, operate, and integrate large, best-in-class clinical research sites with expertise in studies spanning Phases I-IV.
- Mr. Duignan will build the financial infrastructure, lead financial operations, and integrate the acquisitions of the rapidly growing organization.
- "Chris brings with him a deep understanding of our industry and the ability to leverage financial management and reporting to help research sites thrive," said Reinhold Schulz, Chief Executive Officer of Flourish.